SK Capital Partners supports Swixx BioPharma’s global expansion

US-based backstage concern institution SK Capital Partners’ affiliate has agreed to put successful Swixx BioPharma to enactment the latter’s adjacent signifier of maturation and planetary expansion.

The concern values Swixx astatine much than €1.5bn ($1.76bn).

Swixx operates arsenic a commercialisation level for pharma companies, focusing connected markets wherever those companies person chosen not to participate oregon person exited.

The company’s ngo is to supply entree to indispensable medications successful hard-to-reach and underserved regions.

Swixx’s footprint spans Greece, Central and Eastern Europe, Eurasia, respective Commonwealth of Independent States (CIS) countries, Latin America and the Middle East.

The company’s income are anticipated to transcend €1.3bn successful 2026..

As portion of the investment, Swixx’s co-founders Stuart Swanson and Petr Němec, on with CEO Jean-Michel Lespinasse and main fiscal serviceman (CFO) Petr Pipal, volition support important ownership stakes.

Current organization investors HBM Healthcare Investments and Mérieux Equity Partners volition besides stay arsenic shareholders.

Lespinasse commented: “This concern marks a pivotal infinitesimal for Swixx, bringing some further superior and expertise to thrust our growth.

“We stay committed to expanding our relation arsenic the trusted spouse for starring planetary biopharmaceutical companies, delivering sustainable outsourcing solutions successful analyzable and emerging markets — and yet improving entree and outcomes for patients.”

Rothschild & Co is acting arsenic SK Capital’s sole fiscal advisor, with Bär & Karrer and Kirkland & Ellis providing ineligible counsel.

KPMG has advised connected tax, financial, compliance and IT owed diligence, portion ClearView Healthcare Partners supported commercialized owed diligence.

Ares Credit funds provided committed indebtedness financing for the deal.

On Swixx’s side, Jefferies served arsenic pb fiscal advisor. Centerview Partners besides acted arsenic a fiscal advisor and Walder Wyss provided ineligible counsel.

EY offered financial, tax, compliance and ineligible vendor owed diligence services, and BCG contributed to commercialized vendor owed diligence.

As of 31 December 2024, SK Capital manages adjacent to $10bn successful assets.

"SK Capital Partners supports Swixx BioPharma’s planetary expansion" was primitively created and published by Pharmaceutical Technology, a GlobalData owned brand.

The accusation connected this tract has been included successful bully religion for wide informational purposes only. It is not intended to magnitude to proposal connected which you should rely, and we springiness nary representation, warranty oregon guarantee, whether explicit oregon implied arsenic to its accuracy oregon completeness. You indispensable get nonrecreational oregon specializer proposal earlier taking, oregon refraining from, immoderate enactment connected the ground of the contented connected our site.